The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Cell Expansion Technologies-Global Market Insights and Sales Trends 2025
Synopsis
The global Cell Expansion Technologies market size is expected to reach US$ 32170 million by 2029, growing at a CAGR of 10.1% from 2023 to 2029. The market is mainly driven by the significant applications of Cell Expansion Technologies in various end use industries. The expanding demands from the Clinical diagnostics, Drug discovery and development, Regenerative medicine and Others, are propelling Cell Expansion Technologies market. Reagents, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Media segment is estimated at % CAGR for the next seven-year period.
Depending upon the type of cell, the global cell expansion market can be broadly split into human cells and animal cells. The human cell can be further divided into stem cells and differentiated cells. Revenue-wise, the human stem cell segment accounts for a dominant share in the market on account of the rising prevalence of various chronic diseases and support provided by the government. In 2016, it held a substantial 58.1% share in the overall revenue in the global cell expansion market.
Geographically, the key segments of the market are Asia Pacific, Europe, North America, Latin America, and the Middle East and Africa. Among them, North America is the leading market on account of the concentration of many key players in the region and the increasing research and development in the field. Going forward, North America is slated to slightly pare its market share to hold a 37.7% share in it by 2024. It will still, however, remain the dominant market.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Cell Expansion Technologies, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Cell Expansion Technologies market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Cell Expansion Technologies market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Cell Expansion Technologies sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Cell Expansion Technologies covered in this report include Becton, Dickinson, GE Healthcare, Thermo Fisher Scientific Inc., Corning Inc, Danaher Corp, Merck Millipore, Terumo BCT and STEMCELL Technologies, etc.
The global Cell Expansion Technologies market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Becton
Dickinson
GE Healthcare
Thermo Fisher Scientific Inc.
Corning Inc
Danaher Corp
Merck Millipore
Terumo BCT
STEMCELL Technologies
Sigma-Aldrich Corp
Miltenyi Biotec
Life Technologies
Replicell
Neximmune
TC Biopharm
Pluristem Therapeutics
ReNeuron
Voria Biomaterials
CellProthera
Cytomatrix
Global Cell Expansion Technologies market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Cell Expansion Technologies market, Segment by Type:
Reagents
Media
Sera
Disposables
Global Cell Expansion Technologies market, by Application
Clinical diagnostics
Drug discovery and development
Regenerative medicine
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Cell Expansion Technologies companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
The global Cell Expansion Technologies market size is expected to reach US$ 32170 million by 2029, growing at a CAGR of 10.1% from 2023 to 2029. The market is mainly driven by the significant applications of Cell Expansion Technologies in various end use industries. The expanding demands from the Clinical diagnostics, Drug discovery and development, Regenerative medicine and Others, are propelling Cell Expansion Technologies market. Reagents, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Media segment is estimated at % CAGR for the next seven-year period.
Depending upon the type of cell, the global cell expansion market can be broadly split into human cells and animal cells. The human cell can be further divided into stem cells and differentiated cells. Revenue-wise, the human stem cell segment accounts for a dominant share in the market on account of the rising prevalence of various chronic diseases and support provided by the government. In 2016, it held a substantial 58.1% share in the overall revenue in the global cell expansion market.
Geographically, the key segments of the market are Asia Pacific, Europe, North America, Latin America, and the Middle East and Africa. Among them, North America is the leading market on account of the concentration of many key players in the region and the increasing research and development in the field. Going forward, North America is slated to slightly pare its market share to hold a 37.7% share in it by 2024. It will still, however, remain the dominant market.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Cell Expansion Technologies, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Cell Expansion Technologies market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Cell Expansion Technologies market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Cell Expansion Technologies sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Cell Expansion Technologies covered in this report include Becton, Dickinson, GE Healthcare, Thermo Fisher Scientific Inc., Corning Inc, Danaher Corp, Merck Millipore, Terumo BCT and STEMCELL Technologies, etc.
The global Cell Expansion Technologies market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Becton
Dickinson
GE Healthcare
Thermo Fisher Scientific Inc.
Corning Inc
Danaher Corp
Merck Millipore
Terumo BCT
STEMCELL Technologies
Sigma-Aldrich Corp
Miltenyi Biotec
Life Technologies
Replicell
Neximmune
TC Biopharm
Pluristem Therapeutics
ReNeuron
Voria Biomaterials
CellProthera
Cytomatrix
Global Cell Expansion Technologies market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Cell Expansion Technologies market, Segment by Type:
Reagents
Media
Sera
Disposables
Global Cell Expansion Technologies market, by Application
Clinical diagnostics
Drug discovery and development
Regenerative medicine
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Cell Expansion Technologies companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Cell Expansion Technologies
1.1 Cell Expansion Technologies Market Overview
1.1.1 Cell Expansion Technologies Product Scope
1.1.2 Cell Expansion Technologies Market Status and Outlook
1.2 Global Cell Expansion Technologies Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Cell Expansion Technologies Market Size by Region (2018-2029)
1.4 Global Cell Expansion Technologies Historic Market Size by Region (2018-2023)
1.5 Global Cell Expansion Technologies Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Cell Expansion Technologies Market Size (2018-2029)
1.6.1 North America Cell Expansion Technologies Market Size (2018-2029)
1.6.2 Europe Cell Expansion Technologies Market Size (2018-2029)
1.6.3 Asia-Pacific Cell Expansion Technologies Market Size (2018-2029)
1.6.4 Latin America Cell Expansion Technologies Market Size (2018-2029)
1.6.5 Middle East & Africa Cell Expansion Technologies Market Size (2018-2029)
2 Cell Expansion Technologies Market by Type
2.1 Introduction
2.1.1 Reagents
2.1.2 Media
2.1.3 Sera
2.1.4 Disposables
2.2 Global Cell Expansion Technologies Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Cell Expansion Technologies Historic Market Size by Type (2018-2023)
2.2.2 Global Cell Expansion Technologies Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Cell Expansion Technologies Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Cell Expansion Technologies Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Cell Expansion Technologies Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Cell Expansion Technologies Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Cell Expansion Technologies Revenue Breakdown by Type (2018-2029)
3 Cell Expansion Technologies Market Overview by Application
3.1 Introduction
3.1.1 Clinical diagnostics
3.1.2 Drug discovery and development
3.1.3 Regenerative medicine
3.1.4 Others
3.2 Global Cell Expansion Technologies Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Cell Expansion Technologies Historic Market Size by Application (2018-2023)
3.2.2 Global Cell Expansion Technologies Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Cell Expansion Technologies Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Cell Expansion Technologies Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Cell Expansion Technologies Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Cell Expansion Technologies Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Cell Expansion Technologies Revenue Breakdown by Application (2018-2029)
4 Cell Expansion Technologies Competition Analysis by Players
4.1 Global Cell Expansion Technologies Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Cell Expansion Technologies as of 2022)
4.3 Date of Key Players Enter into Cell Expansion Technologies Market
4.4 Global Top Players Cell Expansion Technologies Headquarters and Area Served
4.5 Key Players Cell Expansion Technologies Product Solution and Service
4.6 Competitive Status
4.6.1 Cell Expansion Technologies Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Becton
5.1.1 Becton Profile
5.1.2 Becton Main Business
5.1.3 Becton Cell Expansion Technologies Products, Services and Solutions
5.1.4 Becton Cell Expansion Technologies Revenue (US$ Million) & (2018-2023)
5.1.5 Becton Recent Developments
5.2 Dickinson
5.2.1 Dickinson Profile
5.2.2 Dickinson Main Business
5.2.3 Dickinson Cell Expansion Technologies Products, Services and Solutions
5.2.4 Dickinson Cell Expansion Technologies Revenue (US$ Million) & (2018-2023)
5.2.5 Dickinson Recent Developments
5.3 GE Healthcare
5.3.1 GE Healthcare Profile
5.3.2 GE Healthcare Main Business
5.3.3 GE Healthcare Cell Expansion Technologies Products, Services and Solutions
5.3.4 GE Healthcare Cell Expansion Technologies Revenue (US$ Million) & (2018-2023)
5.3.5 Thermo Fisher Scientific Inc. Recent Developments
5.4 Thermo Fisher Scientific Inc.
5.4.1 Thermo Fisher Scientific Inc. Profile
5.4.2 Thermo Fisher Scientific Inc. Main Business
5.4.3 Thermo Fisher Scientific Inc. Cell Expansion Technologies Products, Services and Solutions
5.4.4 Thermo Fisher Scientific Inc. Cell Expansion Technologies Revenue (US$ Million) & (2018-2023)
5.4.5 Thermo Fisher Scientific Inc. Recent Developments
5.5 Corning Inc
5.5.1 Corning Inc Profile
5.5.2 Corning Inc Main Business
5.5.3 Corning Inc Cell Expansion Technologies Products, Services and Solutions
5.5.4 Corning Inc Cell Expansion Technologies Revenue (US$ Million) & (2018-2023)
5.5.5 Corning Inc Recent Developments
5.6 Danaher Corp
5.6.1 Danaher Corp Profile
5.6.2 Danaher Corp Main Business
5.6.3 Danaher Corp Cell Expansion Technologies Products, Services and Solutions
5.6.4 Danaher Corp Cell Expansion Technologies Revenue (US$ Million) & (2018-2023)
5.6.5 Danaher Corp Recent Developments
5.7 Merck Millipore
5.7.1 Merck Millipore Profile
5.7.2 Merck Millipore Main Business
5.7.3 Merck Millipore Cell Expansion Technologies Products, Services and Solutions
5.7.4 Merck Millipore Cell Expansion Technologies Revenue (US$ Million) & (2018-2023)
5.7.5 Merck Millipore Recent Developments
5.8 Terumo BCT
5.8.1 Terumo BCT Profile
5.8.2 Terumo BCT Main Business
5.8.3 Terumo BCT Cell Expansion Technologies Products, Services and Solutions
5.8.4 Terumo BCT Cell Expansion Technologies Revenue (US$ Million) & (2018-2023)
5.8.5 Terumo BCT Recent Developments
5.9 STEMCELL Technologies
5.9.1 STEMCELL Technologies Profile
5.9.2 STEMCELL Technologies Main Business
5.9.3 STEMCELL Technologies Cell Expansion Technologies Products, Services and Solutions
5.9.4 STEMCELL Technologies Cell Expansion Technologies Revenue (US$ Million) & (2018-2023)
5.9.5 STEMCELL Technologies Recent Developments
5.10 Sigma-Aldrich Corp
5.10.1 Sigma-Aldrich Corp Profile
5.10.2 Sigma-Aldrich Corp Main Business
5.10.3 Sigma-Aldrich Corp Cell Expansion Technologies Products, Services and Solutions
5.10.4 Sigma-Aldrich Corp Cell Expansion Technologies Revenue (US$ Million) & (2018-2023)
5.10.5 Sigma-Aldrich Corp Recent Developments
5.11 Miltenyi Biotec
5.11.1 Miltenyi Biotec Profile
5.11.2 Miltenyi Biotec Main Business
5.11.3 Miltenyi Biotec Cell Expansion Technologies Products, Services and Solutions
5.11.4 Miltenyi Biotec Cell Expansion Technologies Revenue (US$ Million) & (2018-2023)
5.11.5 Miltenyi Biotec Recent Developments
5.12 Life Technologies
5.12.1 Life Technologies Profile
5.12.2 Life Technologies Main Business
5.12.3 Life Technologies Cell Expansion Technologies Products, Services and Solutions
5.12.4 Life Technologies Cell Expansion Technologies Revenue (US$ Million) & (2018-2023)
5.12.5 Life Technologies Recent Developments
5.13 Replicell
5.13.1 Replicell Profile
5.13.2 Replicell Main Business
5.13.3 Replicell Cell Expansion Technologies Products, Services and Solutions
5.13.4 Replicell Cell Expansion Technologies Revenue (US$ Million) & (2018-2023)
5.13.5 Replicell Recent Developments
5.14 Neximmune
5.14.1 Neximmune Profile
5.14.2 Neximmune Main Business
5.14.3 Neximmune Cell Expansion Technologies Products, Services and Solutions
5.14.4 Neximmune Cell Expansion Technologies Revenue (US$ Million) & (2018-2023)
5.14.5 Neximmune Recent Developments
5.15 TC Biopharm
5.15.1 TC Biopharm Profile
5.15.2 TC Biopharm Main Business
5.15.3 TC Biopharm Cell Expansion Technologies Products, Services and Solutions
5.15.4 TC Biopharm Cell Expansion Technologies Revenue (US$ Million) & (2018-2023)
5.15.5 TC Biopharm Recent Developments
5.16 Pluristem Therapeutics
5.16.1 Pluristem Therapeutics Profile
5.16.2 Pluristem Therapeutics Main Business
5.16.3 Pluristem Therapeutics Cell Expansion Technologies Products, Services and Solutions
5.16.4 Pluristem Therapeutics Cell Expansion Technologies Revenue (US$ Million) & (2018-2023)
5.16.5 Pluristem Therapeutics Recent Developments
5.17 ReNeuron
5.17.1 ReNeuron Profile
5.17.2 ReNeuron Main Business
5.17.3 ReNeuron Cell Expansion Technologies Products, Services and Solutions
5.17.4 ReNeuron Cell Expansion Technologies Revenue (US$ Million) & (2018-2023)
5.17.5 ReNeuron Recent Developments
5.18 Voria Biomaterials
5.18.1 Voria Biomaterials Profile
5.18.2 Voria Biomaterials Main Business
5.18.3 Voria Biomaterials Cell Expansion Technologies Products, Services and Solutions
5.18.4 Voria Biomaterials Cell Expansion Technologies Revenue (US$ Million) & (2018-2023)
5.18.5 Voria Biomaterials Recent Developments
5.19 CellProthera
5.19.1 CellProthera Profile
5.19.2 CellProthera Main Business
5.19.3 CellProthera Cell Expansion Technologies Products, Services and Solutions
5.19.4 CellProthera Cell Expansion Technologies Revenue (US$ Million) & (2018-2023)
5.19.5 CellProthera Recent Developments
5.20 Cytomatrix
5.20.1 Cytomatrix Profile
5.20.2 Cytomatrix Main Business
5.20.3 Cytomatrix Cell Expansion Technologies Products, Services and Solutions
5.20.4 Cytomatrix Cell Expansion Technologies Revenue (US$ Million) & (2018-2023)
5.20.5 Cytomatrix Recent Developments
6 North America
6.1 North America Cell Expansion Technologies Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Cell Expansion Technologies Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Cell Expansion Technologies Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Cell Expansion Technologies Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Cell Expansion Technologies Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Cell Expansion Technologies Market Dynamics
11.1 Cell Expansion Technologies Industry Trends
11.2 Cell Expansion Technologies Market Drivers
11.3 Cell Expansion Technologies Market Challenges
11.4 Cell Expansion Technologies Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
